Intralesional agents in the management of cutaneous malignancy: a review.

[1]  M. Foote,et al.  A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series , 2010, Melanoma research.

[2]  A. Turan,et al.  Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNα‐2b and topical imiquimod 5% cream , 2009, International journal of dermatology.

[3]  D. Damian,et al.  Systemic Phototoxicity following Intralesional Rose Bengal for Subcutaneous Melanoma Metastases , 2008, Dermatology.

[4]  D. Whitaker,et al.  Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature. , 2007, Journal of the American Academy of Dermatology.

[5]  G. Kricorian,et al.  5% 5‐Fluorouracil Cream for the Treatment of Small Superficial Basal Cell Carcinoma: Efficacy, Tolerability, Cosmetic Outcome, and Patient Satisfaction , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[6]  H. Williams,et al.  Interventions for basal cell carcinoma of the skin. , 2007, The Cochrane database of systematic reviews.

[7]  K. Seeger,et al.  Therapeutic use of mistletoe for CD30+ cutaneous lymphoproliferative disorder/lymphomatoid papulosis , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  C. Prins,et al.  Intralesional and intravenous treatment of cutaneous B‐cell lymphomas with the monoclonal anti‐CD20 antibody rituximab: report and follow‐up of eight cases , 2006, The British journal of dermatology.

[9]  P. Hersey,et al.  Rose Bengal induces dual modes of cell death in melanoma cells and has clinical activity against melanoma , 2006 .

[10]  S. Tucker,et al.  Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy. , 2006, Journal of the American Academy of Dermatology.

[11]  R. Cheney,et al.  Treatment of primary cutaneous CD30+ anaplastic large cell lymphoma with intralesional methotrexate. , 2006, Journal of the American Academy of Dermatology.

[12]  J. Grob,et al.  Randomized Controlled Study of Electrochemotherapy in the Local Treatment of Skin Metastases of Melanoma , 2006, Journal of cutaneous medicine and surgery.

[13]  C. Hanke,et al.  Treatment of giant keratoacanthoma with intralesional 5-fluorouracil. , 2006, Journal of drugs in dermatology : JDD.

[14]  B. Dréno.  Standard and new treatments in cutaneous B‐cell lymphomas , 2006, Journal of cutaneous pathology.

[15]  R. Dummer,et al.  Intra-lesional low-dose interferon α2a therapy for primary cutaneous marginal zone B-cell lymphoma , 2006, Leukemia & lymphoma.

[16]  Philip R. Cohen,et al.  Pancytopenia after a single intradermal infiltration of methotrexate. , 2005, Journal of drugs in dermatology : JDD.

[17]  I. Zalaudek,et al.  Treatment of primary cutaneous B-cell lymphoma with rituximab. , 2005, Journal of the American Academy of Dermatology.

[18]  P. Hersey,et al.  Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy) , 2005, Melanoma research.

[19]  K. Kwon,et al.  Intralesional interferon alfa-2b treatment of keratoacanthomas. , 2004, Journal of the American Academy of Dermatology.

[20]  P. Cappugi,et al.  New Proposal for the Treatment of Nodular Basal Cell Carcinoma with Intralesional 5-Aminolevulinic Acid , 2004, Journal of chemotherapy.

[21]  D. Hooper,et al.  Treatment of Squamous Cell Carcinoma With Intralesional 5‐Fluorouracil , 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[22]  P. Johnston,et al.  5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.

[23]  D. Calista.  Regression of a cutaneous melanoma metastasis after intralesional cidofovir , 2003, Melanoma research.

[24]  J. Hochman,et al.  Topical Treatment of Bowen's Disease with 5-Fluorouracil , 2003, Journal of cutaneous medicine and surgery.

[25]  W. Gaus,et al.  Intralesional recombinant interferon beta-1a in the treatment of basal cell carcinoma: results of an open-label multicentre study. , 2002, European journal of dermatology : EJD.

[26]  C. Samuel,et al.  Antiviral Actions of Interferons , 2001, Clinical Microbiology Reviews.

[27]  T. Mentzel,et al.  Large B-Cell Lymphoma of the Leg – Complete Remission with Perilesional Interferon Alpha , 2001, Dermatology.

[28]  E. Bröcker,et al.  Pancytopenia after treatment of keratoacanthoma by single lesional methotrexate infiltration. , 2001, Archives of dermatology.

[29]  S. Rodriguez-Cuevas,et al.  Electrochemotherapy in primary and metastatic skin tumors: phase II trial using intralesional bleomycin. , 2001, Archives of medical research.

[30]  D. Aboulafia.  Primary Cutaneous Large B‐Cell Lymphoma of the Legs: A Distinct Clinical Pathologic Entity Treated With CD20 Monoclonal Antibody (Rituximab) , 2001, American journal of clinical oncology.

[31]  R. Moy,et al.  Effect of perilesional injections of PEG-interleukin-2 on basal cell carcinoma. , 2000, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[32]  M. Fimiani,et al.  Guess what! Keratoacanthoma treated with intralesional bleomycin. , 1999, European journal of dermatology : EJD.

[33]  M. Jaroszeski,et al.  Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin , 1998, Cancer.

[34]  E. Orenberg,et al.  Intratumoral chemotherapy with fluorouracil/epinephrine injectable gel: a nonsurgical treatment of cutaneous squamous cell carcinoma. , 1998, Journal of the American Academy of Dermatology.

[35]  C. de la Torre,et al.  Keratoacanthoma centrifugum marginatum: treatment with intralesional bleomycin. , 1997, Journal of the American Academy of Dermatology.

[36]  M. Jaroszeski,et al.  Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. , 1997, Journal of the American Academy of Dermatology.

[37]  E. Alpsoy,et al.  Comparison of the Effects of Intralesional Interferon Alfa‐2a, 2b and the Combination of 2a and 2b in the Treatment of Basal Cell Carcinoma , 1996, The Journal of dermatology.

[38]  A. Solomon,et al.  Intradermal bleomycin injections into normal human skin. A histopathologic and immunopathologic study. , 1994, Archives of dermatology.

[39]  Robert E. Jones,et al.  Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases. , 1993, The American Journal of dermatopathology.

[40]  H. Zarour,et al.  Large keratoacanthomas treated with intralesional interferon alfa-2a. , 1993, Journal of the American Academy of Dermatology.

[41]  A. Wennberg,et al.  Treatment of aggressive basal cell carcinoma with intralesional interferon: evaluation of efficacy by Mohs surgery. , 1992, Journal of the American Academy of Dermatology.

[42]  E. Olsen.  The pharmacology of methotrexate. , 1991, Journal of the American Academy of Dermatology.

[43]  J. Vance,et al.  Intralesional interferon therapy for basal cell carcinoma. , 1990, Journal of the American Academy of Dermatology.

[44]  D. Perednia,et al.  The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomas. , 1990, Archives of dermatology.

[45]  L. Requena,et al.  Aggressive keratoacanthoma of the eyelid: "malignant" keratoacanthoma or squamous cell carcinoma? , 1990, The Journal of dermatologic surgery and oncology.

[46]  R. Carroll,et al.  Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. , 1989, The Journal of dermatologic surgery and oncology.

[47]  C. Hanke,et al.  Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil. , 1986, Journal of the American Academy of Dermatology.

[48]  H. Tagami,et al.  Treatment of keratoacanthoma with intralesional bleomycin , 1983, The British journal of dermatology.

[49]  J. Patterson,et al.  Treatment of multiple keratoacanthomas with intralesional fluorouracil. , 1982, Journal of the American Academy of Dermatology.

[50]  D. Goette,et al.  Successful treatment of keratoacanthoma with intralesional fluorouracil. , 1980, Journal of the American Academy of Dermatology.

[51]  D. Goette,et al.  Treatment of keratoacanthomas with intralesional fluorouracil. , 1978, Archives of dermatology.

[52]  J. Jessup,et al.  Intralesional treatment of recurrent metastatic cutaneous malignant melanoma. A randomized prospective study of intralesional bacillus calmette‐guerin versus intralesional dinitrochlorobenzene , 1978, Cancer.

[53]  U. Wollina.  Complete response of a primary cutaneous T-cell-rich B cell lymphoma treated with interferon α2a , 2012, Journal of Cancer Research and Clinical Oncology.

[54]  Magdalina Gyurova,et al.  Intralesional bleomycin as alternative therapy in the treatment of multiple basal cell carcinomas. , 2006, Dermatology online journal.

[55]  Désirée Ratner,et al.  Current concepts : Basal-cell carcinoma , 2005 .

[56]  J. Wood,et al.  Local treatment of cutaneous and subcutaneous metastatic malignant melanoma with fotemustine , 2004, Cancer Chemotherapy and Pharmacology.

[57]  T. Harr,et al.  Intralesional interferon in basal cell carcinoma: how does it work? , 2002, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[58]  A. Cognetta,et al.  Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel. , 1997, Journal of the American Academy of Dermatology.

[59]  M. Jaroszeski,et al.  Bleomycin-mediated electrochemotherapy of basal cell carcinoma. , 1996, Journal of the American Academy of Dermatology.

[60]  S. Chimenti,et al.  Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma. , 1995, Dermatology.

[61]  E. Epstein.  Intralesional interferon therapy for basal cell carcinoma. , 1992, Journal of the American Academy of Dermatology.

[62]  T. Hindson,et al.  Treatment of neoplastic skin lesions with intralesional interferon. , 1989, Journal of the American Academy of Dermatology.

[63]  D. V. Hoff,et al.  Cancer chemotherapy handbook , 1980 .